Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 12,621 shares at $175.32 ($2.2M) on 2021-10-05, disclosed to the SEC on 2021-10-07.
Open-market sale of $2.2M NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $170.80 | 1,471 | $251K | 11.5% |
| 2 | $170.80 | 1,471 | $251K | 11.5% |
| 3 | $171.86 | 2,200 | $378K | 17.3% |
| 4 | $171.86 | 2,200 | $378K | 17.3% |
| 5 | $172.70 | 700 | $121K | 5.5% |
| 6 | $172.70 | 700 |
| $121K |
| 5.5% |
| 7 | $174.12 | 700 | $122K | 5.6% |
| 8 | $175.32 | 600 | $105K | 4.8% |
| 9 | $176.49 | 500 | $88K | 4.0% |
| 10 | $177.31 | 300 | $53K | 2.4% |
| 11 | $178.37 | 600 | $107K | 4.9% |
| 12 | $179.39 | 400 | $72K | 3.3% |
| 13 | $180.41 | 400 | $72K | 3.3% |
| 14 | $182.05 | 179 | $33K | 1.5% |
| 15 | $183.14 | 200 | $37K | 1.7% |
| Total | $173.45 avg | 12,621 | $2.2M | 100% |
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |